Homology Medicines Advances First Gene Editing Development Candidate into IND-Enabling Studies for Pediatric Patients with ...
- Data Demonstrates Highly Efficient and Selective In Vivo Gene Editing in a Humanized Murine Model - - New Internal GMP Manufacturing Capability to Support Gene Therapy and Gene Editing Programs - BEDFORD, Mass., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Homology …